Patient no., gender, age (years)
Preoperative calcitonin (pg/mL)
Extent of surgery
Histopathology; pTNM
Postoperative calcitonin (pg/mL)
Basal
Peak
Basal
Peak
1.1; f; 78
312
2634
TT, LND central and lateral
Bilateral MTC (10 mm, 11 mm); 1/45 LNM; pT1bpN1aM0
7
48
2.3; m; 46
60
nd
TT, LND central and lateral
Bilateral MTC (3 mm, 5 mm), unilateral PTC (1 mm); 0/31 LNM; pT1apN0M0
<2
<2
3.1.2; m; 17
24
510
TT, LND central
Bilateral MTC (3 mm, 3 mm), 0/7 LNM; pT1apN0M0
<2
<2
3.2.4; f; 10
9
27
TT
Bilateral CCH, no MTC, 0/1 LNM
<2
<2
3.1.3; m; 8
4
79
TT
No CCH, no MTC; 0/1 LNM
<2
<2
3.2.3; m; 8
9
nd
TT
Bilateral CCH, no MTC
<2
<2
3.2.2; m; 6
9
57
TT
Bilateral CCH, no MTC, 0/1 LNM
<2
<2
3.2.1; f; 5
3
nd
TT
Bilateral CCH, no MTC, 0/1 LNM
<2
<2
Fig. 45.1
Pedigree of the 3-generational family carrying the heterozygous S891A RET mutation. Filled circle, filled square Gene carrier (female, male). Open circle, open square Kindred (female, male) without S891A mutation. Open circle with filled square Male index patient of the family. Asterisk Patients with MTC
Evaluation for Surgery
On stimulation with pentagastrin, the adolescent carrier’s calcitonin serum levels rose from 24 pg/mL basally (upper normal limit <8.4 pg/mL; Immulite 2000 assay, Diagnostic Products Corp., Los Angeles, CA) to a peak level of 510 pg/mL after 5 min (patient 3.1.2; Table 45.1, Fig. 45.1). Physical examination of the thyroid gland and high-resolution neck ultrasonography were negative. Thyroid examination of the other eight non-index patients, including ultrasonography, identified multinodular goiter disease without evidence of lymph node metastases in the 78-year-old grandmother (patient 1.1) and a suspicious small hypoechoic lesion in her 46-year-old son (patient 2.3) (Fig. 45.2). With the exception of two 5- and 8-year-old children (patients 3.2.1 and 3.1.3), all non-index patients exhibited elevated basal calcitonin levels. All family members who had a pentagastrin stimulation test performed showed peak calcitonin levels markedly increased over baseline (Table 45.1). None of the eight non-index patients had biochemical or imaging evidence for adrenal medullary or parathyroid disease.